Active

JANPHARMA

Switched

BE0539740563

Rechtspersoon Private limited company 1 establishment

Broekstraat 28, 9255 Buggenhout Activiteiten van holdings

Active for

12 year, 11 months

Financials

Financial year 2025

Gross margin

€ 90,204

▼ 6% vs 2024

Profit

Healthy

€ 46,550

▼ 47% vs 2024

Debts

Normal

€ 789,915

▼ 1% vs 2024

JANPHARMA from Buggenhout, company number BE0539740563, closed financial year 2025 with a result of € 46,550 after tax. For that financial year JANPHARMA recorded a gross margin of € 90,204 and equity of € 321,854. Compared with financial year 2024, the result moved from € 88,326 to € 46,550. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 23, 2026.

What happened at JANPHARMA?

What happened at JANPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 46,550 (▼ 47% vs 2024). Source: NBB ↗
  • New establishment in Buggenhout. KBO
  • Start of the company according to the CBE. KBO
  • Jan Heyvaert became a director. NBB

In short

From € 57,063 profit in 2021 to € 46,550 profit in 2025.

Paid € 108,462 in corporate taxes since 2021.

Best year ever: 2022, with € 131,837 profit.

Paid out € 169,764 in dividends to the owners in total.

A new publication or filing at JANPHARMA? We notify you, reason included.

Follow JANPHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Jan Heyvaert
JANPHARMA

Behind JANPHARMA is Jan Heyvaert. It owns 45% of Opniphar itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Jan Heyvaert

Bestuurder

Also active at: OPNIPHAR

since 2013

Establishments

Establishment units

Physical locations of this company

Registered office

Broekstraat 28

9255 Buggenhout

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0539.740.563
VAT number
BE 0539.740.563
Registered office
Broekstraat 28, 9255 Buggenhout
Names & denominations
JANPHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
30 September 2013
Peppol
Active · Active since 24 Nov 2023
Activities · NACE

Activiteiten van holdings

Holdings

Overige dienstverlenende activiteiten op het gebied van informatie

Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.

Frequently asked questions

What is the enterprise number of JANPHARMA?
The enterprise number of JANPHARMA is BE0539740563.
What is the address of JANPHARMA?
The registered office of JANPHARMA is located at Broekstraat 28, 9255 Buggenhout.
When was JANPHARMA founded?
JANPHARMA was founded on 30 September 2013.
What is the main activity of JANPHARMA?
The main activity of JANPHARMA is "Activiteiten van holdings" (NACE code 64210).
Does JANPHARMA have a website?
No website is currently known for JANPHARMA.
How much profit did JANPHARMA make in 2025?
JANPHARMA posted a profit after taxes of € 46,550 in financial year 2025.
What is the revenue of JANPHARMA?
As a small company, JANPHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 90,204.
Where can I find the annual accounts of JANPHARMA?
JANPHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of JANPHARMA?
According to the 2025 annual accounts, the directors of JANPHARMA are: Jan Heyvaert.
Who owns JANPHARMA?
Behind JANPHARMA is Jan Heyvaert. It owns 45% of Opniphar itself.